By Nigel Somerville, the Deputy Sheriff of AIM | Thursday 2 April 2020
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
A bit of a storm has been blowing up at AIM-listed cash-hungry biotech dog ValiRx (VAL). A General Meeting had been proposed for shareholders to agree to the issue of yet more confetti in order to keep the Grim Reaper from the door but the government decreed Covid-19 lockdown intervened and the meeting could not happen. Yesterday the GM was reconvened with shareholders unable to attend or vote – and two of the three resolutions were passed. But what of legality?...
Already a subscriber? Click here to sign in
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
Search ShareProphets |
Stock market news |
Recent Comments |
Site by Everywhen